{
    "Trade/Device Name(s)": [
        "Diazyme Lipoprotein (a) Assay",
        "Diazyme Lp(a) Assay",
        "Lp(a) Test System"
    ],
    "Submitter Information": "Diazyme Laboratories",
    "510(k) Number": "K082488",
    "Predicate Device Reference 510(k) Number(s)": [
        "K013359"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DFC",
        "JIS",
        "JJX",
        "JIT"
    ],
    "Summary Letter Date": "December 1, 2008",
    "Summary Letter Received Date": "December 4, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "866.5600",
        "862.1150",
        "862.1660"
    ],
    "Regulation Name(s)": [
        "Low-Density Lipoprotein Immunological Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Lipoprotein (a)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Automated chemistry analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Latex enhanced immunoturbidimetric assay",
        "Turbidimetry"
    ],
    "Methodologies": [
        "Immunoturbidimetric quantitation"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Reagent",
        "Instrument",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Diazyme Lipoprotein (a) latex-enhanced immunoturbidimetric assay for quantitative determination of Lp(a) in serum or plasma",
    "Indications for Use Summary": "For quantitative determination of lipoprotein (a) [Lp(a)] concentration in human serum or plasma (EDTA) to aid cardiovascular risk assessment, used in conjunction with clinical evaluation",
    "fda_folder": "Immunology"
}